Cerebrospinal fluid from five Alzheimers disease patients was resolved by electrophoresis, transferred to nitrocellulose membrane, and probed with Mouse Anti-Human CD107a-UNLB (SB Cat. No. 9835-01) followed by an HRP conjugated secondary antibody and chemiluminescent detection. Image from Armstrong A, Mattsson N, Appelqvist H, Janefjord C, Sandin L, Agholme L, et al. Lysosomal network proteins as potential novel CSF biomarkers for Alzheimers disease. Neuromolecular Med. 2014;16:150-60. Figure 2(a)